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Oil extracts of flowering tops of Hypericum richeri Vill. prepared in three different ways were evaluated for chemical 
composition, and anti-inflammatory and gastroprotective activities. An HPLC method was developed for determination of two 
dominant flavonoids, quercetin and I3,II8-biapigenin. The carrageenan-induced rat paw edema test was used for screening the 
anti-inflammatory activity, while indomethacin-induced rat gastric mucosa damage test was used for evaluation of 
gastroprotective activity. The oil extract prepared by maceration with 96% ethanol, followed by extraction with sunflower oil 
by heating on a water bath, exhibited the highest anti-inflammatory (38.4 %) and gastroprotective activities (gastric damage 
score of 0.9). The same oil extract had the highest content of quercetin (49 μg/mL) and I3,II8-biapigenin (60 μg/mL). These 
results approve the usage of oil extracts of H. richeri as an anti-inflammatory and gastroprotective agent. 
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Hypericum richeri Vill. is one of several species of 
Hypericum L. that has been used in traditional medicine 
in the central Balkan countries. This plant belongs to the 
Drosocarpium section and grows in mountain regions 
of south and south-central Europe [1]. Until now,        
H. perforatum L. was the only Hypericum species 
officially accepted in medicine for the treatment of mild 
to moderate depression, anxiety, and externally for 
treatment of inflammation of the skin, blunt injuries, 
wounds and burns [2].  
 
According to our ethnopharmacological investigations, 
aerial blooming parts of H. richeri are used in 
traditional medicine of Montenegro in the form of an 
infusion and as an oil extract [3]. The infusion is used 
for the treatment of different type of inflammation, the 
common cold, dyspepsia and anxiety, while the oil 
extract is traditionally used externally for healing skin 
burns, wounds and injuries, and internally for ulcer 
treatment. Recent reports of the phytochemical profiling 
of H. richeri revealed the presence of many biological 
active compounds, such as quercetin and its glycosides, 
myricetin glycosides, I3,II8-biapigenin, caffeoylquinic 
acids, hypericin, pseudohypericin, and hyperforin [3-5].  
Antimicrobial, antioxidant and anti-inflammatory 
activity of alcoholic extracts of H. richeri have been 
reported [6,7]. Some less polar compounds, such as 
quercetin and biapigenin are extractable in oil. It was 
shown that these flavonoids could contribute to the  
anti-inflammatory and gastroprotective activity of       
H. perforatum oil extracts (Oleum Hyperici) [8].  
 
The present study included chemical characterization  
of H. richeri oil extracts prepared in three different 
ways, as well as investigation of anti-inflammatory  and 
gastroprotective activity of the extracts in order to 
justify their ethnomedicinal use. 
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Table 1: The amount of quercetin and I3,II8-biapigenin in the oil extracts 
of Hypericum richeri.  
 
Quercetin  I3,II8-Biapigenin   Sample 
(μg/mL) (μg/mL) 
Extract 1 27 ± 2 8 ± 1 
Extract 2 49 ± 3 60 ± 4 
Extract 3 22 ± 2 7 ± 1 
 
Two flavonoids, quercetin and I3,II8-biapigenin, were 
identified and quantified in the tested oil extracts of H. 
richeri. The amounts of the flavonoids varied between 
the extracts. Extract 2, prepared by maceration with 
96% ethanol, followed by extraction with sunflower oil 
by heating in a water bath, was characterized by the 
highest content of both compounds. The flavonoid 
contents in extracts 1 and 3 are rather similar (Table 1). 
Ethanol, as a solvent during maceration, probably 
contributed to a better extraction of dry plant material 
resulting in a better yield of flavonoids. On the other 
hand, the condition of the plant material for the 
extraction (fresh or dry) had less influence on the 
flavonoid content. In our earlier studies, it was also 
shown that the procedure for the preparation of H. 
perforatum oil extracts affected the amount of active 
compounds, but the type of solvent was the most 
noticeable [8]. 
 
The anti-inflammatory activity of the oil extracts 
administered p.o. in three doses (0.50 mL/kg, 0.75 
mL/kg, and 1.25 mL/kg) was studied in comparison 
with indomethacin by the carrageenan induced paw 
edema test. Indomethacin, used as a reference drug in a 
dose of 8 mg/kg, led to a 71% decrease of the edema. 
All three tested oil extracts exhibited statistically 
significant anti-inflammatory activity (P < 0.01) in a 
dose dependent manner (Table 2), where only the 
lowest dose of extract 3 did not show statistically 
significant activity compared with the control group that 
received sunflower oil. Extract 2, at a dose of 1.25 
mL/kg, exhibited the strongest anti-inflammatory effect 
(38%). The pure flavonoids, quercetin and I3,II8-
biapigenin, administered p.o. at a dose of 8 mg/kg 
inhibited the edema formation by 59% and 61%, 
respectively, and was almost in the range of the 
standard anti-inflammatory drug indomethacin      
(Table 2). The anti-inflammatory effect of quercetin 
administrated locally on the acute inflammatory process 
has been previously demonstrated [9,10]. Taking into 
account that the anti-inflammatory effect of these 
flavonoids has been shown, and that the highest content 
of both compounds was noticed in extract 2, it is 
expected that this extract would possess the strongest 
anti-inflammatory activity. In our previous paper, oil 
extract of H. perforatum obtained by maceration with 
ethanol also possessed the highest anti-inflammatory 
effect.  Comparing these two Hypericum species,  
 
Table 2: Effects of the oil extracts of Hypericum richeri on carrageenan 
induced rat paw edema and on gastric ulcer after p.o. administration 
 
Groups 
Dose  
(mL/kg) 
Anti-
inflammatory  
effect (%) 
Gastric damage  
score 
Control a / / 3.5 ± 1.2 
Extract 1 0.5 14.9 ± 4.2** 2.7 ± 1.2 
 0.75 16.8 ± 7.7** 2.3 ± 1.0* 
 1.25 24.7 ± 4.2** 1.8 ± 0.5** 
Extract 2 0.5 30.7 ± 9.5** 1.4 ± 0.4* 
 0.75 35.3 ± 5.8** 1.2 ± 0.5** 
 1.25 38.4 ± 7.8** 0.9 ± 0.5** 
Extract 3 0.5 10.7 ± 3.5 2.8 ± 0.7 
 0.75 21.4 ± 6.4** 2.7 ± 0.8* 
 1.25 26.3 ± 7.0** 2.0 ± 1.0* 
Indomethacin b 8 71.5 ± 15.9** 3.8 ± 0.9 
Quercetin b 8 59.0 ±14.7** 0.3 ± 0.2** 
I3,II8-Biapigenin 
b
8 60.9 ± 20.6** 0.2 ± 0.2** 
Ranitidine b  20 / 0.5 ± 0.3** 
a Sunflower oil, p.o. 
b dose of standard is expressed in mg/kg 
Data are presented as the mean ± S.D. (n=6).  
* P < 0.05 significantly different from control group 
** P < 0.01 significantly different from control group (Mann-Whitney U 
test) 
 
H. perforatum oil extracts were more active, probably 
due to a greater amount of quercetin [8]. 
 
Indomethacin, as one of the non-steroid anti-
inflammatory drugs that inhibits prostaglandin 
production, can lead to the formation of gastrointestinal 
ulcer. However, administration of the H. richeri oil 
extracts given immediately after indomethacin, 
significantly (P < 0.01) reduced the gastric lesions, 
except for the lowest doses of extracts 1 and 3. Extract 
2, at a dose of 1.25 mL/kg, showed the highest activity, 
with the lowest gastric damage score of 0.9 (Table 2). 
Pure quercetin and I3,II8-biapigenin also significantly 
reduced the gastric lesions, with a gastroprotective 
activity similar to that of ranitidine. Such results are in 
accordance with our previous investigations of oil 
extracts of H. perforatum [8]. 
 
The results obtained in this study provide evidence for 
the ethnopharmacological usage of oil extracts of H. 
richeri as an anti-inflammatory and gastroprotective 
agent. Quercetin and I3,II8-biapigenin, as identified 
flavonoids in the tested oil extracts, could be partially 
responsible for these activities. In both experimental 
models, extract 2 showed the highest activity, probably 
due to the greatest amount of quercetin and I3,II8-
biapigenin caused by pre-extraction of plant material 
with ethanol. However, comparison of the results 
obtained for the anti-inflammatory and gastroprotective 
activity of H. perforatum oil extracts (Oleum Hyperici) 
[8] and oil extracts of H. richeri indicated that it is more 
favorable to use H. perforatum than H. richeri. 
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Experimental  
 
Plant material: The flowering tops of H. richeri Vill. 
were collected in July 2005 on Bogićevica mountain, 
Montenegro. The voucher specimen No. 314/05 has 
been deposited at the Biology Department, Faculty of 
Science, University of Montenegro, Podgorica. 
 
Preparation of the oil extract: Oil extracts were 
prepared in 3 different ways. The first (extract 1) was 
prepared by maceration of 60 g of fresh flowering tops 
in 300 g of sunflower oil exposed to sunlight for 40 
days; 290 g of extract was obtained.  The second oil 
extract (extract 2) was prepared by maceration of 20 g 
of dried plant material with 60 mL 96% ethanol for 24 h 
at room temperature. After that, extraction was 
continued by the addition of 120 g sunflower oil, 
followed by evaporation of the ethanol by heating the 
mixture for 4 h in a warm bath yielding 110 g of oil 
extract. The third oil extract (extract 3) was prepared by 
digestion of 20 g dried flowering tops in 200 g 
sunflower oil for 3 h yielding 190 g of the oil extract. 
The obtained extracts were filtered and kept at room 
temperature. 
 
HPLC analysis: For HPLC analysis of the extracts, 
further re-extraction with methanol was done. A 50 mL 
portion of each oil extract was re-extracted 3 times with 
50 mL methanol. The methanol extracts were 
combined, evaporated under vacuum at a temperature 
below 50°C and concentrated to 10 mL. The samples 
were filtered through a 0.45 µm filter prior to injection. 
Analyses were carried out on a Hewlett Packard HPLC 
model 1090; DAD detector (HP 1040); column 
Lichrospher RP-18 (5 μm, 250 × 4 mm i.d.) (Merck); 
flow rate 1 mL/min; mobile phase: A (99% H2O, 1% 
H3PO4), B (acetonitrile); elution by combination of 
gradient and isocratic modes: 16–36% B, 0–6 min; 36–
60% B, 6–12 min, 60-80% B, 12–16 min, 80–100% B, 
16–20 min, 100% B, 20–35 min. The absorption was 
measured at 270, 350 and 590 nm. The injection volume 
was 20 μL. Quercetin and I3,II8-biapigenin were 
identified by the co-injection method, using the standard 
compounds previously isolated in our laboratory [3]. 
The amounts of these compounds were calculated using 
calibration curves. Detection was performed at 270 nm. 
Concentrations used for calibration were 0.03-0.2 
mg/mL for I3,II8-biapigenin and 0.03-0.5 mg/mL for 
quercetin. All experiments were conducted in triplicate. 
The results are presented as µg/mL of the oil extract. 
 
Animals: Male, 8-week-old Wistar rats (200-250 g) 
were purchased from the Military Medical Academy 
Animal House, Belgrade. They were housed in a local 
animal house with a controlled light cycle and were 
given commercial food pellets and water ad libitum. 
Each experimental group consisted of 6 animals. The 
animals were deprived of food for 18-20 h before the 
beginning of experiments with free access to tap water. 
Throughout the studies the protocol for these 
experiments was approved by the Institutional Animal 
Care and Use Committee.  
 
Anti-inflammatory activity: The carrageenan-induced 
rat paw edema test has been used as an experimental 
model for screening the anti-inflammatory activity of 
the oil extracts and pure compounds according to the 
modified method of Oyanagui and Sato [11]. The 
extracts were administered p.o. in different doses (0.50 
mL/kg, 0.75 mL/kg, and 1.25 mL/kg). Indomethacin, 
dissolved in DMSO, was used as a reference drug at a 
dose of 8 mg/kg p.o. Quercetin and I3,II8-biapigenin, 
dissolved in sunflower oil, were used at a dose of 8 
mg/kg p.o. The control animals were given sunflower 
oil in a dose of 1.25 mL/kg p.o. Carrageenan-saline 
solution (0.5% in a volume of 0.1 mL) was injected into 
the plantar surface of the right hind paw 1 h after the 
oral administration of the sunflower oil, oil extracts, 
quercetin, I3,II8-biapigenin or indomethacin. A pure 
saline solution (0.9%, 0.1 mL) was injected into the left 
hind paw, which served as the control (non-inflamed 
paw). The animals were sacrificed by ether anesthesia 
3 h after the carrageenan injection and the paws were 
cut off for weighing. A difference in weight between the 
right and left paw, treated versus untreated (control) 
rats, served as an indicator of the inflammatory 
response intensity (i.e. anti-inflammatory activity). It 
was calculated from the expression:  
Inflammatory response intensity (%)=(Δk – Δe)×100/Δk  
where Δk is the difference in the paw weight in the 
control group and Δe is the difference in the paw weight 
in the treatment groups. 
 
Gastroprotective activity: In order to study the 
gastroprotective activity of the oil extracts and pure 
compounds, an experimental model of acute gastric 
mucosal damage induced by indomethacin in a dose of 
8 mg/kg p.o. was utilized. Extracts and sunflower oil 
were given in different doses (0.50 mL/kg, 0.75 mL/kg, 
and 1.25 mL/kg) p.o. immediately after indomethacin. 
Quercetin and I3,II8-biapigenin, dissolved in sunflower 
oil, were used in a dose of 8 mg/kg p.o. Ranitidine (20 
mg/kg p.o.) was used as a reference drug. The animals 
were sacrificed 4 h after that and their stomachs were 
removed and opened along the greater curvature. 
Lesions were examined under an illuminated magnifier 
(3×). The intensity of gastric lesions was assessed 
according to the total length of gastric lesions (mm) and 
the lesion area (mm2), as well as to a modified scoring 
system of Adami et al. [12].  
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Statistical analysis: Data are presented as mean ± 
standard deviation (SD). The Mann-Whitney U-test was 
applied using the program SPSS11.5 for Windows for 
comparison of data between groups. Differences were 
considered statistically significant at P < 0.05.  
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